Tamoxifen is a drug that is used to treat breast cancer. It inhibits the activities of the estrogen receptor in breast epithelial cells, which are the cells that are relevant to breast cancer. One of the concerns that scientists had during the development of tamoxifen as a therapy for breast cancer was that other cell types require estrogen signaling for their function. For example, it is known that cells in bone tissue require estrogen signaling. As a result, there was a concern that use of tamoxifen would lead to bone loss in patients. In reality, however, researchers were surprised to find that tamoxifen actually led to an increase in bone density in breast cancer patients. At the same time, tamoxifen did inhibit the activity of the estrogen receptor in breast epithelial cells in
these patients. What is the best explanation for this finding?
A. Tamoxifen binds different parts of the estrogen receptor in different tissues.
B. Bone cells make use of a different type of estrogen receptor that does not bind to tamoxifen.
C. The estrogen receptor is bound to different coactivators in different tissues.
D. Tamoxifen can only enter certain cell types.
Answer: C
You might also like to view...
The R and S genes are linked and 10 map units apart. In the cross R s / r S × r s / r s what percentage of the progeny will be R s / r s?
A) 5% B) 10% C) 25% D) 40% E) 45%
The hormonal control over excretion most likely occurs in the
a. Bowman's capsule. b. proximal tubule. c. distal tubule. d. loop of Henle. e. urinary bladder.
Methylmalonic acidemia is caused by _____
A. an overdose of ethylene glycol B. fat accumulation in white blood cells C. defective liver enzymes D. the inability to metablolize amino acids and fats E. destruction of myelin sheaths surrounding nerves
Antifungal drugs used to treat superficial mycoses work by
A) Disrupting fungal membrane permeability and inhibiting sterol synthesis B) Disrupting RNA function C) Altering glucose metabolism D) Inhibiting protein synthesis